Skip to main content

Olga Simó Servat

Institutions of which they are part

Main researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Olga Simó Servat

Institutions of which they are part

Main researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

H2O Health Outcomes Observatory

IP: Yolima Cossio Gil
Collaborators: Alba García Zarzoso, Rafael Simó Canonge, Maria Carmen Baraldés Vallverdú, Joan Carles Peiró Ruiz, Monica Sanchez Bartres, H2O Health Outcomes Observatory, Xavier Serra Ruiz, Marta Ferri Peradalta, Olga Simó Servat, Elena Céspedes Martínez, Ernesto Alejand Lastiri González
Funding agency: The Innovative Medicines Initiative
Funding: 1097257.5
Reference: H2O_IMI2-2020
Duration: 01/10/2020 - 30/04/2026

Microperimetry and serum biomarkers for identifying type 2 diabetic patients with cognitive impairment. A cross-sectional and prospective study.

IP: Olga Simó Servat
Collaborators: Ana Boixadera Espax, Angel Michael Ortiz Zúñiga, Marina Giralt Arnaiz, Microperimetry and serum biomarkers for identifying type 2 diabetic patients with cognitive impairment. A cross-sectional and pr
Funding agency: Instituto de Salud Carlos III
Funding: 82280
Reference: PI20/01703
Duration: 01/01/2021 - 30/06/2025

Destí: QUEEN'S UNIVERSITY BELFAST. Proposta: Increasing the skill set on diabetic retinopathy in the clinical setting and sharing basic research between QUB and VHIR

IP: Olga Simó Servat
Collaborators: Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 5850
Reference: MV17/00044
Duration: 01/01/2018 - 31/03/2018

Non-invasive assessment of advanced glycation end-products (AGEs) and diabetic outcomes: an integrated pilot study

IP: Cristina Hernández Pascual
Collaborators: Angel Michael Ortiz Zúñiga, Andreea Ciudin Mihai, Olga Simó Servat
Funding agency: European Foundation for the Study of Diabetes
Funding: 98000
Reference: AGE_EFSDSANOFI2017
Duration: 01/09/2017 - 31/08/2018

Related news

The families of the professionals had the opportunity to visit the facilities and discover how we work at the institution.

The document provides recommendations for identifying people who are candidates for these treatments and for guiding their implementation and follow-up in clinical practice.

The publications update the pharmacological management guideline for obesity and its complications and present the first European comprehensive management guideline for patients with obesity treated with medications.

Related professionals

Clara Alsius Rance

Clara Alsius Rance

Gestió i Administració
Fundraising Unit
Communication Directorate
Read more
Montserrat Mohedano Fret

Montserrat Mohedano Fret

Gestió i Administració
Fundraising Unit
Communication Directorate
Read more
Marina Serena Calderon

Marina Serena Calderon

Gestió i Administració
Secretariat for Governance and Science Policy
Internal Strategy Directorate
Read more
Maria del Carmen Llorente Olmedo

Maria del Carmen Llorente Olmedo

Research assistant
Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.